12 results

• Breast Cancer Survivors File Lawsuit Over Recalled BioZorb Tissue Marker

  March 12, 2025

  Irvin Jackson

  A BioZorb tissue marker lawsuit representing five women from across the country claims that the recalled implant was defectively designed, resulting in a recall and numerous complications.

• Joint BioZorb Marker Lawsuit Claims Implant Caused Seroma, Infections and Other Complications

  February 4, 2025

  Irvin Jackson

  A lawsuit filed by six women claim the recalled BioZorb implant was defectively designed, causing pain, infections, swelling and fears of a return of their breast cancer.

• Judge Clears BioZorb Breast Marker Lawsuit To Move Forward, Rejecting Motion for Summary Judgment

  January 9, 2025

  Irvin Jackson

  In a ruling likely to apply broadly across the litigation, a federal judge is refusing to dismiss a BioZorb marker lawsuit, clearing the way for other claims to move forward.

• Problems With Recalled BioZorb Markers Could Cause Severe Injury or Death, FDA Warns

  December 19, 2024

  Irvin Jackson

  The FDA is giving a recent BioZorb marker recall a class I designation, indicating the federal agency believes problems with the device, implanted to assist in targeted therapy in breast cancer patients, can cause serious injuries and potentially death.

• Hologic Seeks To Dismiss BioZorb Design Defect Claims in Lawsuits Over Recalled Tissue Marker

  November 14, 2024

  Irvin Jackson

  Although a BioZorb recall has been issued for all versions of the breast tissue markers sold by Hologic, the manufacturer is asking a federal judge to throw out lawsuits alleging that injuries were caused by design defects.

• BioZorb Lawsuit Indicates Recalled Tissue Marker Migrated After It Failed To Absorb, Resulting in Severe Pain and Surgical Removal

  November 7, 2024

  Irvin Jackson

  Days after the FDA announced a BioZorb recall, an Arkansas woman has filed a lawsuit, indicating that her BioZorb tissue marker migrated out of position, causing pain and disfigurement, instead of harmlessly absorbing into the body as advertised.

• BioZorb Recall Issued for All Breast Tissue Markers Following Implant Migration, Erosion Problems

  October 25, 2024

  Irvin Jackson

  The FDA is calling for doctors to stop using BioZorb Marker implants, due to serious complications in breast cancer patients, which has led Hologic to remove all remaining devices from the market.

• Amended Lawsuit Over BioZorb Implant Side Effects Outlines Problems Caused By Tissue Marker Design Defects

  September 4, 2024

  Irvin Jackson

  Six breast cancer patients have asked a federal judge for permission to amend a complaint filed in March 2024, which describes problems linked to the device and painful side effects experienced when the tissue marker migrated out of position or shattered inside their bodies.

• BioZorb Injury Lawsuits Are Being Prepared For Trial in July 2025 in District of Massachusetts

  August 14, 2024

  Irvin Jackson

  A group of four lawsuits over the BioZorb marker will be selected for a series of early bellwether trial dates starting in July 2025, which are designed to help gauge how juries may respond to evidence that will be repeated throughout claims that the tissue marker caused painful complication.

• BioZorb Implant Complications Result in Lawsuit Brought by 7 Breast Cancer Survivors

  July 26, 2024

  Irvin Jackson

  A Biozorb tissue marker lawsuit filed by seven women claim the implant is defectively designed, and prone to cause a variety of complications, such as pain, lumps, device migration and infections.